Hammarskiöld acted as legal adviser to Biosergen AB. Biosergen AB (publ) secured a rights issuance of shares and warrants. Biosergen’s shares are listed on Nasdaq First North...
Biosergen AB’s Rights Offering
Biosergen’s SEK 50 Million Issue of Units And Listing on Nasdaq First North Growth Market Close
Lindahl has advised Biosergen AB on the deal. Biosergen has carried out an issue of 5,000,000 units to the public in Sweden, Denmark and Norway. Through...
Biosergen’s SEK 50 Million Issue of Units And Listing on Nasdaq First North Growth Market Close
Lindahl has advised Biosergen AB on the deal. Biosergen has carried out an issue of 5,000,000 units to the public in Sweden, Denmark and Norway. Through...